LESCARDEN INC
10QSB, EX-27, 2001-01-10
PHARMACEUTICAL PREPARATIONS
Previous: LESCARDEN INC, 10QSB, 2001-01-10
Next: PILGRIM WORLDWIDE EMERGING MARKETS FUND INC, N-30D, 2001-01-10



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM LESCARDEN
INC.'S NOVEMBER 30,2000 FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY
REFERNCE TO SUCH FINANCIAL LEGENDS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAY-31-2001
<PERIOD-END>                               NOV-30-2000
<CASH>                                          48,450
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                     87,300
<CURRENT-ASSETS>                               135,750
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 135,750
<CURRENT-LIABILITIES>                          372,806
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        22,369
<OTHER-SE>                                   (259,425)
<TOTAL-LIABILITY-AND-EQUITY>                   135,750
<SALES>                                         17,921
<TOTAL-REVENUES>                                17,921
<CGS>                                                0
<TOTAL-COSTS>                                  261,625
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              (243,704)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (243,704)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (243,704)
<EPS-BASIC>                                   (0.01)
<EPS-DILUTED>                                   (0.01)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission